Caveolin Muscle Repair

Caveolin Muscle Repair - Supplemental Material can be found...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin * S Received for publication, October 24, 2007, and in revised form, November 26, 2007 Published, JBC Papers in Press, December 20, 2007, DOI 10.1074/jbc.M708776200 Delia J. Herna ´ndez-Deviez , Mark T. Howes , Steven H. Laval § , Kate Bushby § , John F. Hancock , and Robert G. Parton ‡¶1 From the Institute for Molecular Bioscience, Centre for Microscopy and Microanalysis, University of Queensland, Brisbane, Queensland 4072, Australia and the § Institute of Human Genetics, International, Centre for Life, Newcastle NE1 3BZ, United Kingdom Dysferlin and Caveolin-3 are plasma membrane proteins associated with muscular dystrophy. Patients with mutations in the CAV3 gene show dysferlin mislocalization in muscle cells. By utilizing caveolin-null cells, expression of caveolin mutants, and different mutants of dysferlin, we have dis- sected the site of action of caveolin with respect to dysferlin trafficking pathways. We now show that Caveolin-1 or -3 can facilitate exit of a dysferlin mutant that accumulates in the Golgi complex of Cav1 ± / ± cells. In contrast, wild type dysfer- lin reaches the plasma membrane but is rapidly endocytosed in Cav1 ± / ± cells. We demonstrate that the primary effect of caveolin is to cause surface retention of dysferlin. Caveolin-1 or Caveolin-3, but not specific caveolin mutants, inhibit endocytosis of dysferlin through a clathrin-independent pathway colocalizing with internalized glycosylphosphatidy- linositol-anchored proteins. Our results provide new insights into the role of this endocytic pathway in surface remodeling of specific surface components. In addition, they highlight a novel mechanism of action of caveolins relevant to the pathogenic mechanisms underlying caveolin-associated disease. Dysferlin and Caveolin-3 (muscle-specific caveolin, Cav3) are sarcolemmal proteins whose role in muscle has gained clin- ical attention because mutations in their genes are associated with a number of muscle pathologies. Patients with mutations in the dysferlin ( DYSF ) gene develop disorders such as limb girdle muscular dystrophy type 2B, miyoshi myopathy, and dis- tal myopathy (1–5). Whereas disruption in the Caveolin-3 ( CAV3 ) gene has been linked to limb girdle muscular dystrophy 1C, Rippling muscle diseases, hyperCKemia, and distal myopa- thy among other myopathies (6–15). Dysferlin and Cav3 have been co-purified from muscle cells (16, 17) and shown to local- ize to adjacent membrane domains at the surface in mature muscle fibers (18). Moreover, dysferlin is depleted from the plasma membrane (PM) 2 when Cav3 is mutated (8, 9, 14, 17, 19). We have recently demonstrated a role for caveolin in dys- ferlin localization at the PM (18). However, the interplay of dysferlin and caveolin membrane trafficking dynamics remains to be examined.
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/12/2010 for the course BC BC367 taught by Professor Millard during the Spring '10 term at Colby.

Page1 / 13

Caveolin Muscle Repair - Supplemental Material can be found...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online